A free educational event about Hepatitis C is to be held in Nottingham, following news of plans by the NHS to be the first to eliminate Hepatitis C.
The event will be for health professionals, commissioners, drug service professionals working in the West Midlands, East Midlands, or East of England, and comes just days after NHS England announced plans to be the first to eliminate Hepatitis C, at least five years earlier than the World Health Organisation goal of 2030.
The event will be hosted by HCV Action and NHS England, and will take place at the De Vere East Midlands Conference Centre on Beeston Lane on Friday, March 9 from 10:00-16:30.
Attendees can expect talks and workshops on the Hepatitis C landscape by professionals in the region.
For the full programme click here
Hepatitis C is currently a major public health issue globally, accounting for around 400,000 deaths per year. Recent figures show that it is affecting around 160,000 people in the UK.
The NHS has invested in Hepatitis C treatment each year as new treatments became available, but doctors, patient groups and NHS leaders believe it is possible to go further and are encouraging pharmaceutical companies to work with them to eliminate the disease.
Part of the new agreements between NHS England and drug companies will involve collaboration to identify more people who are living with Hepatitis C and need to be treated.
Experts believe that this approach, combined with the NHS sustaining the same level of investment and the best new treatments being used, could undoubtedly lead to Hepatitis C being eradicated as a major public health concern in the very near future.
Professor Graham Foster, National Clinical Chair for Hepatitis C, NHS England said: “The progress made in the treatment of Hepatitis C has transformed the lives of many of my patients and has been made possible by NHS England working closely with industry to bring prices down and expand treatment options.
“Yet we have the opportunity to do so much more.”
“Over the last seven decades, the NHS has been at the forefront of medical innovation. To be able to commit to a world first in the year of the NHS’ 70th anniversary would be another remarkable and truly historic achievement.”
England is one of the few countries in Europe where numbers of patients receiving new oral treatments for Hepatitis C are already increasing year on year enabled by deals previously agreed.